REFERENCES
- Linnen J, Wages J Jr, Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science. 1996;271:505–508.
- Tacke M, Kiyosawa K, Stark K, et al. Detection of antibod-ies to a putative hepatitis G virus envelope protein. Lancet. 1997;349:318–320.
- Fiordalisi G, Bettinardi A, Zanella I, et al. Parenteral and sexual transmission of GB virus C and hepatitis C virus among human immunodeficiency virus-positive patients. J Infect Dis. 1997;175:1025–1026.
- Bonacini M, Qian D, Govindarajan S, Valinluck B. Preva-lence of hepatitis G virus RNA in the sera of patients with HIV infection. J Acquir Immune Defic Syndr Hum RetroyiroL 1998;19:40–43.
- Woolley I, Valdez H, Walker C, et al. Hepatitis G virus RNA is common in AIDS patients' plasma but is not associated with abnormal liver function test or other clinical syn-dromes. J Acquir Immune Defic Syndr Hum RetroyiroL 1998;19:408–412.
- Rey D, Fraize S, Vidinic J, et al. High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodeficiency virus. J Med ViroL 1999;57:75–79.
- Schreier E, Höhne M, Künkel U, Berg T, Hoof U. Hepatitis GBV-C sequences in patients infected with HCV contami-nated anti-D immunoglobulin and among IV drug users in Germany. J HepatoL 1996;25:385–389.
- Yoshiba M, Okammoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulmi-nant hepatitis of unknown aetiology. Lancet. 1995;346:1131–1132.
- Centers for Disease Control and Prevention. 1994 revised classification system for HIV infection in children less than 13 years of age. MMWR. 1994;43:1–10.
- Nübling CM, Löwer J. GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin. Lan-cet. 1996;347:68.
- Feucht HH, Zöllner B, Polywka S, Laufs R. Vertical transmis-sion of hepatitis G virus. Lancet. 1996;347:615–616.
- Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipi-ents of plasma products. Lancet. 1996;348:1352–1355.
- Kinoshita T, Miyake K, Nakao H, et al. Molecular investiga-tion of GB virus C infection in hemophiliacs in Japan. J Infect 0is. 1997;175: 454–457.
- Feucht HH, Zöllner B, Polywka S, et al. Prevalence of hepa-titis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J Clin MicrobioL 1997;35:767–768.
- Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus co-infection on the course of HIV infection in hemophilia patients in Japan. J AIDS Human Retrovirol. 1998;17:209–213.
- Nerurkar VR, Chua PK, Hoffmann PR, Dashwood WM, Shikuma CM, Yanagihara R. High prevalence of GB virus C/ hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: Evidence for sexual transmission. J Med ViroL 1998;56:123–127.
- Zehender G, De Maddalena C, Bosisio AB, et al. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users. J Hum Virol. 1998;1:96–110.
- Lefrere JJ, Roudor-Thoraval F, Morand-Joubert L, et al. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: Evidence of sexual and parenteral transmission. Transfusion. 1999;39:83–94.
- Halasz R, Fischler B, Nemeth A, Lundholm S, Sällberg M. A high prevalence of serum GB virus C/hepatitis G virus RNA in children with and without liver disease. Clin Infect Dis. 1999;28:537–540.
- Infante D, Pich M, Tormo R, et al. Prevalence of hepatitis G virus in healthy children in liver disease, and human immu-nodeficiency virus-1 infection: Response to interferon. J Pediatr Gastroenterol Nutr. 2000;30:385–390.
- Balistreri WF. "G" —another form of viral hepatitis? J Pediatr. 1997;131:503-506.